Recom Bio (Shanghai Ruikang Biotechnology R&D Co., Ltd.), founded in October 2020, leverages cutting-edge synthetic biology technologies and automated intelligent high-throughput biofoundry platforms to develop high-value-added products focused on biomedical active ingredients, as well as raw materials for natural cosmetics and health products. We have developed multiple efficient chassis strains and a proprietary enzyme library of millions of IP-protected enzyme sequences. Our core R&D talents come from top research institutions globally with extensive synthetic biology experience.
Guided by the tenet “Reconstructing cell factories to create a green future”, we advance through independent innovation and external partnerships to transcend industrial involution. By sharing the Group’s premium industrial ecological resources together with industry partners, we are developing a synthetic biology CDMO platform, aiming to become a globally competitive leader in synthetic biology.